Tamar Galili - Ilex Medical Chief Officer
| ILX Stock | 8,221 18.00 0.22% |
Executive
Ms. Tamar Galili was appointed Chief Executive Officer at Ilex Medical Ltd. effective February 4, 2016. Her work experience at the Company includes the following roles Executive Vice President of Sales and Marketing, Vice President of Marketing Director of Sales and Director . She holds a Bachelors degree in History and Philosophy of Science from Tel Aviv University. since 2016.
| Age | 51 |
| Tenure | 8 years |
| Phone | 972 3 938 5501 |
| Web | https://www.ilexmedical.com |
Ilex Medical Management Efficiency
The company has return on total asset (ROA) of 0.1165 % which means that it generated a profit of $0.1165 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1923 %, meaning that it generated $0.1923 on every $100 dollars invested by stockholders. Ilex Medical's management efficiency ratios could be used to measure how well Ilex Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | EXECUTIVE Age | ||
| Margalit Werner | Hilan | 62 | |
| Ran Efraty | Rami Levi | 53 | |
| Ilan Israeli | Danel | 48 | |
Management Performance
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 |
Ilex Medical Leadership Team
Elected by the shareholders, the Ilex Medical's board of directors comprises two types of representatives: Ilex Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ilex. The board's role is to monitor Ilex Medical's management team and ensure that shareholders' interests are well served. Ilex Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ilex Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ziv Dahari, Vice President - Business Development | ||
| Andrea ADV, Legal Sec | ||
| Claude Benshaul, VP Technologies | ||
| Tamar Galili, Chief Officer | ||
| Saar Oz, VP Sales | ||
| Moshe Shaul, Chairman of the Board | ||
| Yacov Mishan, Chief Officer | ||
| M Schachter, Head VP | ||
| Amir Kleinstern, CEO Flight |
Ilex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ilex Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.18 % | |||
| Current Valuation | 901.49 M | |||
| Shares Outstanding | 11.19 M | |||
| Shares Owned By Insiders | 62.44 % | |||
| Shares Owned By Institutions | 10.16 % | |||
| Price To Book | 1.83 X | |||
| Price To Sales | 1.16 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Ilex Stock
Ilex Medical financial ratios help investors to determine whether Ilex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ilex with respect to the benefits of owning Ilex Medical security.